Conference abstract · 4 May 2020
Conference abstractPublished 21 Oct 2020
Liposomal nanodelivery system targeting epha2 receptor for sensitizing prostate cancer to enhance the efficiency of chemotherapy
National Institute of Pharmaceutical Education and Research, Guwahati, Assam, India.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Liposomal nanodelivery targeting EphA2 receptor for sensitizing prostate cancer to enhance the efficiency of chemotherapy: The quality of life in cancer chemotherapy decreases due to adverse effects associated with chemotherapeutic drugs caused by non-specific action, immunogenicity, and reduced drug penetration. In the current study, we have fabricated Lithocholic acid tryptophan conjugate (LCAT) based liposomal nanodelivery system targeting cancer specifically through EphA2 receptors which shows an interesting feature that these receptors are highly expressed in cancer tissues, but not in normal tissues. We have encapsulated the anticancer drug niclosamide in this delivery system that has shown an average particle size of 207.8 ± 1.91 nm, a poly dispersity index of 0.384 ± 0.02, with an average Zeta potential -29.13 ± 0.7 mV and its encapsulation efficiency was 73.82 ± 1.61%. Niclosamide loaded LCAT formulations (LCAT-NIC-NPS) has shown significant cytotoxicity in EphA2 highly expressed cells (PC 3) but not in EphA2 low expressed (H4) cells. In vitro cellular uptake studies of coumarin-6 loaded LCAT formulation by flowcytometry and confocal microscopy have shown a significant increase in uptake by PC-3 cells compared to H4 cells which indicates that this delivery system is acting through EphA2 receptor. In vivo antitumor efficacy data in PC-3 xenograft reveals that LCAT-NIC-NPS has shown a significant suppression of tumor growth with a 4 fold reduction in the tumor weight and tumor volume compared to disease control. Western blotting and histopathology data reveals that it is acting via EphA2 receptors and has no toxicity on vital organs.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 9 Apr 2018
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
Conference abstract · 13 Mar 2019
Evaluating the effect of low level laser on liposomes containing chemotherapy drug (Docetaxel) and compare with prescribed chemotherapy drugs (Docetaxel) procedure in prostate cancer cells in vitro optic and laser
Conference abstract · 2019
SIRT1 siRNA loaded cationic liposomes showed enhanced cell death of prostate cancer cells with different p53 expression patterns
Conference abstract · 29 May 2017
Bone Microenvironment Targeted Nanoparticles for Metastatic Prostate Cancer Treatment
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectNanotechnology
- SubjectNephrology & Urology
- BylineArticles whose byline prints “JANNU ARUN KUMAR”
